Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer’s disease
Claudio Liguori, Agostino Chiaravalloti, Marzia Nuccetelli, et al.
Journal of Neurology (2017) Vol. 264, Iss. 11, pp. 2215-2223
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases
Chunmei Wang, Qinqin Wang, Bingyuan Ji, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 163
Brain mechanisms underlying neuropsychiatric symptoms in Alzheimer’s disease: a systematic review of symptom-general and –specific lesion patterns
Yaojing Chen, Mingxi Dang, Zhanjun Zhang
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 150
Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial
W. Joseph Herring, Paulette Ceesay, Ellen Snyder, et al.
Alzheimer s & Dementia (2020) Vol. 16, Iss. 3, pp. 541-551
Open Access | Times Cited: 138
Sleep Quality and Aging: A Systematic Review on Healthy Older People, Mild Cognitive Impairment and Alzheimer’s Disease
Maria Casagrande, Giuseppe Forte, Francesca Favieri, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 14, pp. 8457-8457
Open Access | Times Cited: 91
Neuropeptides Exert Neuroprotective Effects in Alzheimer's Disease
Xinyi Chen, Yifeng Du, Lei Chen
Frontiers in Molecular Neuroscience (2019) Vol. 11
Open Access | Times Cited: 99
Pineal gland dysfunction in Alzheimer’s disease: relationship with the immune-pineal axis, sleep disturbance, and neurogenesis
Juhyun Song
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 68
Sleep-Wake Cycle in Alzheimer’s Disease Is Associated with Tau Pathology and Orexin Dysregulation
Claudio Liguori, Matteo Spanetta, Francesca Izzi, et al.
Journal of Alzheimer s Disease (2020) Vol. 74, Iss. 2, pp. 501-508
Closed Access | Times Cited: 64
Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer’s disease course
Claudio Liguori, Fabio Placidi, Francesca Izzi, et al.
Alzheimer s Research & Therapy (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 60
The Lateral Hypothalamus: An Uncharted Territory for Processing Peripheral Neurogenic Inflammation
Marc Fakhoury, Israa Salman, Wassim Najjar, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 50
Suvorexant ameliorates cognitive impairments and pathology in APP/PS1 transgenic mice
Fang Zhou, Xudong Yan, Chun Wang, et al.
Neurobiology of Aging (2020) Vol. 91, pp. 66-75
Closed Access | Times Cited: 50
Disorders of Body Weight, Sleep and Circadian Rhythm as Manifestations of Hypothalamic Dysfunction in Alzheimer’s Disease
Abigail J. Hiller, Makoto Ishii
Frontiers in Cellular Neuroscience (2018) Vol. 12
Open Access | Times Cited: 48
Sleep and its regulation: An emerging pathogenic and treatment frontier in Alzheimer’s disease
Brianne A. Kent, Howard Feldman, Haakon B. Nygaard
Progress in Neurobiology (2020) Vol. 197, pp. 101902-101902
Open Access | Times Cited: 45
Involvement of orexin nerves in early stage of Alzheimer's disease model mice and preventive effect of orexin receptor antagonists
Kazuhiro Hada, Yuki Murata, Yoshiaki Ohi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Cerebrospinal-fluid Orexin-A levels in different neurocognitive disorders: a comparison study
Susana Lozano-Tovar, Riccardo Cremascoli, Marzia Nuccetelli, et al.
Neurological Sciences (2025)
Open Access
Phospho-S129 Alpha-Synuclein Is Present in Human Plasma but Not in Cerebrospinal Fluid as Determined by an Ultrasensitive Immunoassay
Cristina Cariulo, Paola Martufi, Margherita Verani, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 39
Cerebrospinal Fluid Correlates of Neuropsychiatric Symptoms in Patients with Alzheimer’s Disease/Mild Cognitive Impairment: A Systematic Review
Alireza Showraki, Geetanjali Murari, Zahinoor Ismail, et al.
Journal of Alzheimer s Disease (2019) Vol. 71, Iss. 2, pp. 477-501
Closed Access | Times Cited: 39
Role of the orexin system in the bidirectional relation between sleep and epilepsy: New chances for patients with epilepsy by the antagonism to orexin receptors?
Chiara Berteotti, Carmen Calvello, Claudio Liguori
Epilepsia (2023) Vol. 64, Iss. 8, pp. 1991-2005
Open Access | Times Cited: 12
CSF pro-orexin and amyloid-β38 expression in Alzheimer's disease and frontotemporal dementia
Wendy Heywood, Jenny Hällqvist, Amanda Heslegrave, et al.
Neurobiology of Aging (2018) Vol. 72, pp. 171-176
Open Access | Times Cited: 30
Cerebrospinal Fluid Orexin Levels and Nocturnal Sleep Disruption in Alzheimer’s Disease Patients Showing Neuropsychiatric Symptoms
Claudio Liguori, Nicola Biagio Mercuri, Marzia Nuccetelli, et al.
Journal of Alzheimer s Disease (2018) Vol. 66, Iss. 3, pp. 993-999
Closed Access | Times Cited: 30
Association between autophagy and rapid eye movement sleep loss-associated neurodegenerative and patho-physio-behavioral changes
Amit Kumar Singh Chauhan, Birendra Nath Mallick
Sleep Medicine (2019) Vol. 63, pp. 29-37
Closed Access | Times Cited: 28
Dysregulation of the orexin/hypocretin system is not limited to narcolepsy but has far‐reaching implications for neurological disorders
Chiara Berteotti, Claudio Liguori, Marta Pace
European Journal of Neuroscience (2020) Vol. 53, Iss. 4, pp. 1136-1154
Closed Access | Times Cited: 25
The role of orexin in Alzheimer disease: From sleep-wake disturbance to therapeutic target
Fan Gao, Tao Liu, Miao Tuo, et al.
Neuroscience Letters (2021) Vol. 765, pp. 136247-136247
Closed Access | Times Cited: 22
Sleep disorders in Alzheimer’s disease: the predictive roles and potential mechanisms
Fen‐Fang Hong, Shu‐Long Yang, Huang Kuang, et al.
Neural Regeneration Research (2021) Vol. 16, Iss. 10, pp. 1965-1965
Open Access | Times Cited: 20
Tau Biomarkers in Dementia: Positron Emission Tomography Radiopharmaceuticals in Tauopathy Assessment and Future Perspective
Maria Ricci, Andrea Cimini, Riccardo Camedda, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 13002-13002
Open Access | Times Cited: 20
Association Between Appetite and Sarcopenia in Patients With Mild Cognitive Impairment and Early-Stage Alzheimer's Disease: A Case-Control Study
Ai Kimura, Taiki Sugimoto, Shumpei Niida, et al.
Frontiers in Nutrition (2018) Vol. 5
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top